alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                      37,764,000
<SECURITIES>                                20,024,000
<RECEIVABLES>                               17,990,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            81,486,000
<PP&E>                                      27,384,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             118,295,000
<CURRENT-LIABILITIES>                       49,740,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                          2000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               118,295,000
<SALES>                                     45,179,000
<TOTAL-REVENUES>                            45,179,000
<CGS>                                       20,340,000
<TOTAL-COSTS>                               20,340,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                5000
<INCOME-PRETAX>                              1,958,000
<INCOME-TAX>                                   666,000
<INCOME-CONTINUING>                          1,292,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,292,000
<EPS-PRIMARY>                                     0.06
<EPS-DILUTED>                                     0.06
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) RAYTEL
MEDICAL CORPORATION AND SUBSIDIARIES FINANCIAL STATEMENTS AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH (B) FINANCIAL STEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                           8,246
<SECURITIES>                                         0
<RECEIVABLES>                                   30,634<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                42,008
<PP&E>                                          37,317
<DEPRECIATION>                                (17,825)
<TOTAL-ASSETS>                                 118,560
<CURRENT-LIABILITIES>                           15,697
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             9
<OTHER-SE>                                      63,024
<TOTAL-LIABILITY-AND-EQUITY>                   118,560
<SALES>                                              0
<TOTAL-REVENUES>                                25,864
<CGS>                                                0
<TOTAL-COSTS>                                   22,735
<OTHER-EXPENSES>                                   190
<LOSS-PROVISION>                                     0<F2>
<INTEREST-EXPENSE>                                 729
<INCOME-PRETAX>                                  2,210
<INCOME-TAX>                                       884
<INCOME-CONTINUING>                              1,326
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,326
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .14
<FN>
<F1>(RECEIVABLES) REPRESENTS NET RECEIVABLES.
<F2>(LOSS PROVISION) INCLUDED IN (TOTAL COSTS)
</FN>
        

</TABLE>
#### Townsend *v.*Tompkins.

*(Supreme Court, General Term, Second Department.*

July 18, 1890.)

Insurance—Liability of Insured for Services of Agent.

One dealing with a fire insurance company through an intervening agent is not liable to the latter ior his services in making out the policy.

Appeal from Dutchess county court.

Action by John M. Townsend against Mary *G.*Tompkins. A judgment rendered for plaintiff by the justice, before whom the cause was tried, was affirmed by the county court, and defendant appeals.

Argued before Barnard, P. J., and Dykman and Pratt, JJ.

*W. Farrington,*for appellant. *Lewis Balter,*for respondent.

Dykman, J.

The plaintiff commenced this action in a court of a justice •of the peace to recover the value of his services in writing a policy of fire insurance for the defendant, and upon the trial it appeared that he was an agent of a fire insurance company, and made out a policy of insurance for the defendant, and delivered the same to her, which she returned in a few days. The justice rendered a judgment for the plaintiff, which was affirmed on appeal to the county court, and the defendant has appealed from the judgment of affirmance to the court. Our conclusion is that the defendant incurred no obligation to the plaintiff in the transactions she had with him respecting the insurance. She dealt with the insurance company through the plaintiff as the intervening agent. The judgment should therefore be reversed, with costs. All concur.
#### In re MERTZ’S ESTATE.

(Supreme Court, Appellate Division, Fourth Department.

April, 1896.)

Judicial settlement of the intermediate accounts of Loren M. Kittsley, as executor, etc., of John Merz, deceased.

No opinion, Order affirmed, with costs against the appellant personally.
Exhibit 13.2

GPC Biotech AG

Certification Pursuant to 18 U.S.C. Section 1350 as Enacted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

GPC
Biotech AG (the Company) is filing with the U.S. Securities and Exchange Commission, on the date hereof, its annual report on Form 20-F for the fiscal year ended December 31, 2006 (the Report). Pursuant to 18 U.S.C.
Section 1350 as enacted pursuant to the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, I, Mirko Scherer, the Chief Financial Officer of the Company, hereby certify that:

To the best of my knowledge:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | the information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------

Date: June 21, 2007



|                        |  | 
|----------------------- |  | 
|/s/ Mirko Scherer       |  | 
|Mirko Scherer           |  | 
|Chief Financial Officer |  | 

A signed original of this written statement required by Section 906 has been provided to the Company and will
be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 65, Number 74 (Monday, April 17, 2000)]
[Notices]
[Pages 20473-20474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel Fluorescent Indicator Dyes for Extracellular 
Ions (SBIR).
    Date: May 4, 2000.
    Time: 9:00 AM to 11:00 AM.
    Agenda: To review and evaluate contract proposals.
    Place: 6701 Rockledge Drive, Room 4212, Bethesda, MD 20817 
(Telephone Conference Call).

[[Page 20474]]

    Contact Person: David T. George, PhD, Review Branch, NIH, NHLBI, 
DEA, Rockledge II, 6701 Rockledge Drive, Suite 7188, Bethesda, MD 
20892-7924, (301) 435-0280

    .Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel SCOR in Transfusion Biology and Medicine.
    Date: June 8, 2000.
    Time: 7:30 AM to 6:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn--Silver Spring, 8777 Georgia Avenue, Silver 
Spring, MD 20910.
    Contact Person: Deborah P. Beebe, PhD, Leader, Cardiology/
Pulmonary Scientific Review Group, Rockledge Center II, 6701 
Rockledge Drive, Suite 7178, Bethesda, MD 20892-7924, (301) 435-0270

.(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: April 7, 2000.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-9439 Filed 4-14-00; 8:45 am]
BILLING CODE 4140-01-M
Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended
March 31, 2011, I, Craig J. Tuttle, Chief Executive Officer of Transgenomic, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:



| | (1) | Such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended March 31, 2011, fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in such Quarterly Report on Form 10-Q of Transgenomic, Inc. for the quarter ended March 31, 2010, fairly presents, in all material
respects, the financial condition and results of operations of Transgenomic, Inc.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ CRAIG J. TUTTLECraig J. TuttlePresident and Chief Executive Officer


Date:
May 13, 2011

A signed original of the certification required by Section 906 has been provided to Transgenomic, Inc.
and will be retained by Transgenomic, Inc and furnished to the Securities and Exchange Commission or its staff upon request.



33
#### MYERS et al., Respondents, v. ROCHESTER & H. V. R. CO., Appellant.

(Supreme Court, General Term, Fifth Department.

January 18, 1894.)

Action by Thomas A. Myers and others against the Rochester & Honeoye Valley Railroad Company.

No opinion. Judgment appealed from affirmed, with costs.
EXHIBIT
 32



CERTIFICATION
 OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANICAL OFFICER
 PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
 OF 2002



In
 connection with the report on Form10-K ofComCam
 International, Inc. for the annual period endedDecember
 31, 2009, as
 filed with the Securities and Exchange Commission on the date hereof, I,Don Gilbreath,
 do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the
 best of my knowledge and belief:

| | (1) | This report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------------------------

| | (2) | The information contained in this report fairly represents, in all material respects, the financial condition of the registrant at the end of the period covered by this report and results of operations of the registrant for the period covered by this report.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date:April16,
 2010



/s/
 Don Gilbreath

Don
 Gilbreath

Chief
 Executive Officer



This
 certification accompanies this report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required
 by the Sarbanes-Oxley Act of 2002, be deemed filed by the registrant for the purposes of §18 of the Securities Exchange Act of
 1934, as amended. This certification shall not be incorporated by reference into any filing under the Securities Act of 1933, as
 amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this report), irrespective of
 any general incorporation language contained in such filing.   A signed original of this written statement required by
 §906 has been provided to the registrant and will be retained by the registrant and furnished to the Securities and Exchange
 Commission or its staff upon request.



40
Exhibit 32.1   SKINOVATION PHARMACEUTICAL INCORPORATED   CERTIFICATION OF PERIODIC REPORT Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 18 U.S.C. Section 1350  The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:  • the annual report on Form 10-K of the Company for the year ended December 31, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  • the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.  Date:  January 20, 2012/s/Hugo Rodier
Hugo Rodier
Principal Executive Officer
Principal Financial Officer
Exhibit 32.3



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of The PBSJ Corporation (the Company) on Form 10-K/A for the period ending September 30, 2003, as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Robert J. Paulsen, Chief Operating Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and



(2) The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|             |  |  |  |     |  |                          |  |                                                                                  
|------------ |  |  |  | --- |  | ------------------------ |  | ---------------------------------------------------------------------------------
|             |  |  | 
|May 14, 2004 |  |  |  | By: |  | /s/    ROBERT J. PAULSEN
|             |  |  |  |     |  |                          | 
|             |  |  |  |     |  |                          |  | Robert J. Paulsen Chief Operating Officer, Executive Vice President and Secretary
1 

UNITED STATES OF AMERICA

DEPARTMENT OF HOMELAND SECURITY

UNITED STATES COAST GUARD

UNITED STATES COAST GUARD

Complainant 

vs. 

JAY CARL HEICHELHEIM

Respondent. 

)

) 

) 

) 

) 

) 

) 

Docket Number: 2023-0382

MISLE Activity ID: 7786108

WITHDRAWAL FROM DOCKET

The Coast Guard initiated an administrative proceeding by filing a Complaint on October 30, 

2023, seeking a revocation or suspension of Respondent’s Merchant Mariner Credential. 

On Nov 20 , 2023, the Coast Guard filed a Notice of Withdrawal from docket as: 

Respondent completed a Voluntary Surrender Agreement and Coast Guard respectfully 

withdraws this administrative proceeding in accordance with 33 CFR § 20.311(a)(2) 

This matter is removed from the docket and closed without prejudice effective November 20, 

2023. The Coast Guard reserves the right to file a new Complaint in this matter.

Done and Dated November 20, 2023 at 

Baltimore, MD

 

____________________________ 

Cheri Morin

Administrative Support Assistant

U.S. Coast Guard 

By Direction of the Chief Administrative Law Judge
<PAGE>


Exhibit 3.5 Amendment to Certificate of Incorporation to Indigo Energy, Inc.




                          CERTIFICATE OF AMENDMENTS OF
                         CERTIFICATE OF INCORPORATION OF
                               INDIGO ENERGY, INC.


Indigo Energy, Inc., a corporation organized and existing under and by virtue of
the General Corporation Law of the State of Delaware,

DOES HEREBY CERTIFY:

FIRST: The Certificate of Incorporation of Indigo Energy, Inc. is amended by
changing the First Article thereof so that, as amended, said Article shall be
and read as follows:

"The name of the corporation is Global Wireless Satellite Networks (USA), Inc."

SECOND: The Certificate of Incorporation of the Company is amended in Article
Fourth to reflect a 1:10 reverse stock split and reauthorize 100,000,000 shares
of stock consisting of 90,000,000 shares of common stock with a par value of
$.001 per share, and 10,000,000 shares of preferred stock with a par value of
$.001 per share as follows:

         Article Fourth should read as follows:

         "The total number of shares of stock which the corporation shall have
         authority to issue is 100,000,000, of which 90,000,000 shares shall be
         Common Stock, $.001 par value, and 10,000,000 of which shall be
         Preferred Stock, $.001 par value, which shall be subject to the
         provisions of Article Fifth."

THIRD: That in lieu of a meeting and vote of stockholders, the stockholders have
given majority written consent to said amendments in accordance with the
provisions of Section 228 of the General Corporation Law of the State of
Delaware.

FOURTH: That the aforesaid amendment was duly adopted in accordance with the
applicable provisions of Sections 242 and 228 of the General Corporation Law of
the State of Delaware.

IN WITNESS WHEREOF, said Indigo Energy, Inc. has caused this certificate to be
signed by Scott Kostiuk, its Secretary, and Joel Bloomer, its President, this
3rd day of September, 2003.


/s/ Scott Kostiuk                              /s/ Joel Bloomer
-----------------------------                  ----------------------------
Scott Kostiuk, Secretary                       Joel Bloomer, President
IIB 

114TH CONGRESS 

2D SESSION H. R. 2607 

IN THE SENATE OF THE UNITED STATES 

JUNE 22, 2016 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at 7802 37th Avenue in Jackson Heights, New 

York, as the ‘‘Jeanne and Jules Manford Post Office 

Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


smartinez on DSK3GLQ082PROD with BILLS
2 

HR 2607 RFS

1 SECTION 1. JEANNE AND JULES MANFORD POST OFFICE 

2 BUILDING. 

3 (a) DESIGNATION.—The facility of the United States 

4 Postal Service located at 7802 37th Avenue in Jackson 

5 Heights, New York, shall be known and designated as the 

6 ‘‘Jeanne and Jules Manford Post Office Building’’. 

7 (b) REFERENCES.—Any reference in a law, map, reg8 ulation, document, paper, or other record of the United 

9 States to the facility referred to in subsection (a) shall 

10 be deemed to be a reference to the ‘‘Jeanne and Jules 

11 Manford Post Office Building’’. 

Passed the House of Representatives June 21, 2016. 

Attest: KAREN L. HAAS, 

Clerk. 


smartinez on DSK3GLQ082PROD with BILLS
| Name of Subsidiary                              |   | Jurisdiction of  Organization         |
|-------------------------------------------------|--------|---------------------------------------|
| BAK      International Limited             |   | Hong      Kong                        |
| BAK      International (Tianjin) Ltd.      |   | People’s      Republic of China |
| Shenzhen      BAK Battery Co., Ltd.        |   | People’s      Republic of China |
| BAK      Electronics (Shenzhen) Co., Ltd.  |   | People’s      Republic of China |
| BAK      Battery Canada Ltd.               |   | Canada                                |
| BAK Europe      GmbH                       |   | Germany                               |
| BAK      Telecom India Private Limited     |   | India                                 |

----
1.
    
    I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.;
 2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;
 4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
    /s/ JEFFREY ANDRESONJeffrey AndresonExecutive Vice President, Finance and Administration,
Chief Financial Officer, Treasurer and Secretary